Bryce Harper

I think this is a really, really interesting conversation.

I talked to him after Crochet's last start about what their plan was, how they approached it.

And, you know, again, we deal in science and math, and in this case, entertainment and information.

All right, I hope everybody enjoys.

I know that's a lot of numbers being thrown around, but it's a very, very important exercise to understand where these pitchers are doing, where they're going, and who might be running on fumes and who might not be.

And if they don't run on fumes, why they aren't?

And if they do run on fumes, what happened?

What can they learn from it?

All right, here you go.

Here's Brad Pearson, VP of Sports Medicine.

All right, there's no human being on the planet I'd rather be talking to more than Brad Pearson right now.

Not only because he went to the greatest institution ever in Springfield College, but because he's one of the straws that stirs a drink.

There's a lot going on there.

I compliment you a lot, but thanks for talking to me.

So one of the things that I was talking to Alex Cora about this, about how it's changed in terms of the medical side of things of getting starters, getting pitchers really, all pitchers through a season.

I remember back in the day it was like, well, let's do a fake IL stint to give a guy a break.

And maybe there's still that going on.

But from your perspective, how has things changed?

How have things evolved?

Has there been one or two things that have been sort of difference makers, evolutions when it comes to this line of thinking or has it just been monitoring everything a little bit better?